Trial Profile
A phase II trial investigating use of dCellVax (IDO silenced dendritic cell vaccine) in breast cancer patients
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 23 Jun 2015
Price :
$35
*
At a glance
- Drugs IDO-silenced dendritic cell vaccine Regen BioPharma (Primary)
- Indications Breast cancer
- Focus Therapeutic Use
- 23 Jun 2015 New trial record